iifl-logo-icon 1

Genomic Valley Biotech Ltd Share Price

54.86
(5.00%)
Jul 18, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open54.6
  • Day's High54.86
  • 52 Wk High64.2
  • Prev. Close52.25
  • Day's Low52.25
  • 52 Wk Low20.65
  • Turnover (lac)3.5
  • P/E0
  • Face Value10
  • Book Value11.6
  • EPS0.05
  • Mkt. Cap (Cr.)16.76
  • Div. Yield0
No Records Found

Genomic Valley Biotech Ltd KEY RATIOS

Sector

Miscellaneous

Open

54.6

Prev. Close

52.25

Turnover(Lac.)

3.5

Day's High

54.86

Day's Low

52.25

52 Week's High

64.2

52 Week's Low

20.65

Book Value

11.6

Face Value

10

Mkt Cap (₹ Cr.)

16.76

P/E

0

EPS

0.05

Divi. Yield

0

Genomic Valley Biotech Ltd Corporate Action

5 Sep 2023

12:00 AM

AGM

Announcement Date: 05 Sep, 2023

arrow

5 Sep 2023

12:00 AM

BookCloser

arrow

3 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Genomic Valley Biotech Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Genomic Valley Biotech Ltd SHAREHOLDING SNAPSHOT

20 Jul, 2024|08:55 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 64.20%

Foreign: 0.00%

Indian: 64.20%

Non-Promoter- 35.79%

Institutions: 0.00%

Non-Institutions: 35.79%

Custodian: 0.00%

Share Price

Genomic Valley Biotech Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

3.05

3.05

3.05

3.05

Preference Capital

0

0

0

0

Reserves

0.47

-0.18

1.43

1.99

Net Worth

3.52

2.87

4.48

5.04

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

0.2

0.84

0.59

0.44

yoy growth (%)

-75.42

42.41

34.71

304.75

Raw materials

-0.08

0.06

-0.04

-0.09

As % of sales

39.2

8

7.61

22.13

Employee costs

-0.08

-0.17

-0.33

-0.24

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

-0.5

0.2

0.03

-0.06

Depreciation

-0.18

-0.17

-0.07

-0.04

Tax paid

-0.05

0.08

-0.02

0

Working capital

-0.34

0.93

-0.73

-0.07

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-75.42

42.41

34.71

304.75

Op profit growth

-125.09

447.15

-197.41

-77.54

EBIT growth

-184.11

934.17

-153.38

-79.74

Net profit growth

-295.47

738.92

-149.71

-79.51

View Ratios

No Record found

Genomic Valley Biotech Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Godrej Agrovet Ltd

GODREJAGRO

824.4

44.215,849.9736.441.211,486.97117.5

Indegene Ltd

INDGN

581.4

100.9413,911.0948.90272.571.66

Thomas Cook (India) Ltd

THOMASCOOK

248.95

117.4311,715.3117.160.24284.9539.36

RattanIndia Enterprises Ltd

RTNINDIA

75.72

20.4610,466.55-80.7402.016.86

CMS Info Systems Ltd

CMSINFO

515.6

24.168,392.02111.311.12580.71116.06

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Genomic Valley Biotech Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Yogesh Agrawal

Director

Parul Agrawal

Addtnl Independent Director

Kapoor Chand Garg

Addtnl Independent Director

RAHUL KUMAR PATHAK

Independent Director

Gupta Pradeep

Additional Director

Jyoti Bansal

Additional Director

praveen Kumar Mishra

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Incorporated in the year 1994,Genomic Valley Biotech Ltd is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally. The company is extensively involved in commercial greenhouse / poly house cultivation of crops.Presently the company is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer. Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.The company has identified a cluster of 300 marginal farmers eligible to form a Farmers Producer Company. The company is in the process to do all the documentations for getting started with the operation of the Producer Company.The company has already started opening a training centre, imparting trainings to farmers and agri-entrepreneurs profitably. Response in brisk and is escalating day by day with the more and more recognition of the setup and services. Separate courses have been designed for Training like the Ladies to develop kitchen gardens
Read More

Company FAQs

What is the Genomic Valley Biotech Ltd share price today?

Down Arrow

The Genomic Valley Biotech Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹54.86 today.

What is the Market Cap of Genomic Valley Biotech Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Genomic Valley Biotech Ltd is ₹16.76 Cr. as of 18 Jul ‘24

What is the PE and PB ratio of Genomic Valley Biotech Ltd?

Down Arrow

The PE and PB ratios of Genomic Valley Biotech Ltd is 0 and 4.73 as of 18 Jul ‘24

What is the 52 Week High and Low of Genomic Valley Biotech Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Genomic Valley Biotech Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Genomic Valley Biotech Ltd is ₹20.65 and ₹64.2 as of 18 Jul ‘24

What is the CAGR of Genomic Valley Biotech Ltd?

Down Arrow

Genomic Valley Biotech Ltd's CAGR for 5 Years at 46.07%, 3 Years at 34.59%, 1 Year at 152.46%, 6 Month at 31.88%, 3 Month at 50.71% and 1 Month at 20.28%.

What is the shareholding pattern of Genomic Valley Biotech Ltd?

Down Arrow

The shareholding pattern of Genomic Valley Biotech Ltd is as follows:
Promoters - 64.20 %
Institutions - 0.00 %
Public - 35.80 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.